Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?". Ahlstrom MG. Ann Surg Oncol 2024 Aug 17. doi: 10.1245/s10434-024-15944.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ahlstrom MG. Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?". Ann Surg Oncol 2024 Aug 17. doi: 10.1245/s10434-024-15944.
PMID: 39154155